Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
3841-3849 (2008)
Smiles: CC(=O)N1CCN(CC1)C1C=CC(=CC=1)OC[C@H]1CO[C@@](CN2C=NC=C2)(O1)C1=CC=C(Cl)C=C1Cl
Smiles: OC(=O)C1CCN(CC1)C1=NC=C(C=C1Cl)C(=O)NC1=NC(=C(S1)N1CCN(CC1)C1CCCCC1)C1=CC(Cl)=CS1
Smiles: CC1C=CC(=CC=1)C1C2=C(N)N=CN=C2N(CCCO)C=1C(=O)CF
Laquinimod Catalog No.:M11360-2 3841-3849 (2008)Laquinimod, also known as, is an experimental immunomodulator developed by Active Biotech and Teva. It is being investigated as an oral treatment for multiple sclerosis (MS). Laquinimod is the successor of Active Biotech's failed experimental immunomodulator linomide. Laquinimod seems to be able to reduce the MS disease activity on MRI. In 2011, Teva announced its clinical trials involving laquinimod had failed, being unable to significantly reduce
US$ 195.00
US$ 175.00
US$ 105.00
US$ 180.00
US$ 145.00
US$ 520.00
US$ 120.00
US$ 152.50
US$ 50.00
US$ 170.00
US$ 865.00